In a research report released today, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on shares of MannKind Corporation (NASDAQ:MNKD) and raised the …
MannKind Corporation (NASDAQ:MNKD) announced the appointment of Dr. Raymond Urbanski as its Chief Medical Officer.
MannKind Corporation (NASDAQ:MNKD) shares spiked 6.28% in pre-market trading to $4.
MannKind Corporation (NASDAQ:MNKD) reported financial results for the second quarter ended June 30, 2015. For the three and six months ended June 30, 2015, …
Earnings season is beginning to slow down, but Wall Street still has a busy week ahead as Alibaba Group Holding Ltd (NYSE:BABA), MannKind Corporation …
In a research report released this morning, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on shares of MannKind Corporation (NASDAQ:MNKD) with a …
In a research report published on Monday, RBC Capital analyst Adnan Butt reiterated an Outperform rating on shares of MannKind Corporation (NASDAQ:MNKD), but reduced the …
Synergy Pharmaceuticals Synergy Pharmaceuticals Inc (NASDAQ:SGYP) had an incredible day in the market yesterday after announcing the results of it’s second of two …
MannKind Corporation (NASDAQ:MNKD) announced that it has completed the validation of two additional filling lines for the manufacture of Afrezza(R) (insulin human) inhalation powder. …
MannKind Corporation (NASDAQ:MNKD) announced that it has completed the validation of two additional filling lines for the manufacture of Afrezza® (insulin human) inhalation powder. …
